Boothbay Fund Management »

Revolution Medicines shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $14M 300k 46.70
2025-06-30 $6.8M 186k 36.79
2025-03-31 $6.2M 176k 35.36
2023-09-30 $1.1M 41k 27.68

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Gbl Comm Svc Etf Put Option (IXP)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl C Call Option (GOOG)
Amazon Call Option (AMZN)
Select Sector Spdr Tr Indl Put Option (XLI)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Broadcom (AVGO)
Cornerstone Strategic Value (CLM)
Advanced Micro Devices Call Option (AMD)
Apple Call Option (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Revolution Medicines

Vanguard Group
Farallon Capital Management
Henderson Group
Wellington Management Company
Baker Bros. Advisors
FMR
BlackRock
Nextech Invest
Paradigm Biocapital Advisors
Bellevue Group
State Street Corporation
T. Rowe Price Investment Management
Alphabet
BVF
Deerfield Management Company

View all funds holding Revolution Medicines